Sentiment-Signal
23,0
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
53.8
0 neu, 1 erhöht, -815845K $ netto
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 27.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 11.03.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 14.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; C |
| 23.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 17.11.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 11.07.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 22.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment |
| 02.03.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
| 09.01.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; |
Stammdaten
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Unternehmen & Branche
| Name | NOVAVAX INC |
|---|---|
| Ticker | NVAX |
| CIK | 0001000694 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 670002104 |
|---|---|
| ISIN | US6700021040 |
| Typ | Common Stock |
| Marktkapitalisierung | 1,27 Mrd. USD |
| Beta | 2,65 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 1,123,479,000 | 440,302,000 | 2.58 | 1,176,512,000 | -127,753,000 |
| 2025-09-30 | 10-Q | 70,445,000 | -202,379,000 | -1.25 | 1,179,889,000 | -156,672,000 |
| 2025-06-30 | 10-Q | 239,240,000 | 106,508,000 | 0.62 | 1,336,549,000 | 37,625,000 |
| 2025-03-31 | 10-Q | 666,655,000 | 518,646,000 | 2.93 | 1,292,992,000 | -75,643,000 |
| 2024-12-31 | 10-K | 682,162,000 | -187,499,000 | -1.23 | 1,560,418,000 | -623,841,000 |
| 2024-09-30 | 10-Q | 84,512,000 | -121,300,000 | -0.76 | 1,712,483,000 | -526,436,000 |
| 2024-06-30 | 10-Q | 415,484,000 | 162,381,000 | 0.99 | 1,818,646,000 | -431,706,000 |
| 2024-03-31 | 10-Q | 93,855,000 | -147,550,000 | -1.05 | 1,353,534,000 | -867,084,000 |
| 2023-12-31 | 10-K | 983,705,000 | -545,062,000 | -5.41 | 1,797,490,000 | -716,927,000 |
| 2023-09-30 | 10-Q | 186,986,000 | -130,776,000 | -1.26 | 1,657,157,000 | -678,350,000 |
| 2023-06-30 | 10-Q | 424,426,000 | 58,008,000 | 0.58 | 1,685,048,000 | -754,519,000 |
| 2023-03-31 | 10-Q | 80,951,000 | -293,905,000 | -3.41 | 1,542,699,000 | -895,582,000 |
| 2022-12-31 | 10-K | 1,981,872,000 | -657,939,000 | -8.42 | 2,258,679,000 | -634,078,000 |
| 2022-09-30 | 10-Q | 734,577,000 | -168,613,000 | -2.15 | 2,267,437,000 | -565,985,000 |
| 2022-06-30 | 10-Q | 185,925,000 | -510,485,000 | -6.53 | 2,622,993,000 | -416,950,000 |
| 2022-03-31 | 10-Q | 703,971,000 | 203,408,000 | 2.56 | 2,834,875,000 | 65,324,000 |
| 2021-12-31 | 10-K | 1,146,290,000 | -1,743,751,000 | -23.44 | 2,576,753,000 | -351,673,000 |
| 2021-09-30 | 10-Q | 178,844,000 | -322,431,000 | -4.31 | 2,565,941,000 | 461,336,000 |
| 2021-06-30 | 10-Q | 298,017,000 | -352,317,000 | -4.75 | 2,749,587,000 | 745,562,000 |
| 2021-03-31 | 10-Q | 447,229,000 | -222,719,000 | -3.05 | 2,608,366,000 | 1,039,127,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 15,470,365 | 0 | 15,470,365 | 103,960,853 | Neu | +100,0% | |
| SHAH CAPITAL MANAGEMENT | 14,558,780 | 0 | 14,558,780 | 97,835,002 | Neu | +100,0% | |
| BlackRock, Inc. | 12,901,549 | 0 | 12,901,549 | 86,698,409 | Neu | +100,0% | |
| STATE STREET CORP | 9,523,646 | 0 | 9,523,646 | 63,998,901 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 8,290,665 | 0 | 8,290,665 | 55,713,268 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 6,408,998 | 0 | 6,408,998 | 43,068,467 | Neu | +100,0% | |
| UBS Group AG | 4,894,284 | 0 | 4,894,284 | 32,889,587 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 4,512,583 | 0 | 4,512,583 | 30,324,558 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3,721,323 | 0 | 3,721,323 | 25,012,096 | Neu | +100,0% | |
| MORGAN STANLEY | 3,717,984 | 0 | 3,717,984 | 24,984,861 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 3,313,619 | 0 | 3,313,619 | 22,267,520 | Neu | +100,0% | |
| Sculptor Capital LP | 12,875,600 | 0 | 12,875,600 | 18,738,912 | Neu | +100,0% | |
| Graham Capital Management, L.P. | 2,571,220 | 0 | 2,571,220 | 17,278,598 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 2,425,777 | 0 | 2,425,777 | 16,301,221 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 2,403,327 | 0 | 2,403,327 | 16,150,358 | Neu | +100,0% | |
| Allianz Asset Management GmbH | 2,324,142 | 0 | 2,324,142 | 15,618,234 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 1,864,343 | 0 | 1,864,343 | 12,528,385 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1,474,259 | 0 | 1,474,259 | 9,907,021 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 1,453,976 | 0 | 1,453,976 | 9,770,718 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,335,053 | 0 | 1,335,053 | 8,971,556 | Neu | +100,0% | |
| BARCLAYS PLC | 1,102,300 | 0 | 1,102,300 | 7,407,455 | Neu | +100,0% | |
| Monaco Asset Management SAM | 1,045,000 | 0 | 1,045,000 | 7,022,400 | Neu | +100,0% | |
| IMC-Chicago, LLC | 1,035,083 | 0 | 1,035,083 | 6,955,758 | Neu | +100,0% | |
| SIMPLEX TRADING, LLC | 970,700 | 0 | 970,700 | 6,523,104 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 930,011 | 0 | 930,011 | 6,249,673 | Neu | +100,0% | |
| Caption Management, LLC | 925,850 | 0 | 925,850 | 6,221,712 | Neu | +100,0% | |
| FMR LLC | 2,172,941 | 0 | 2,172,941 | 4,719,405 | Neu | +100,0% | |
| Walleye Trading LLC | 655,480 | 0 | 655,480 | 4,404,826 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 623,812 | 0 | 623,812 | 4,192,017 | Neu | +100,0% | |
| ORACLE INVESTMENT MANAGEMENT INC | 600,000 | 0 | 600,000 | 4,032,000 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 512,929 | 0 | 512,929 | 3,446,883 | Neu | +100,0% | |
| CANADA PENSION PLAN INVESTMENT BOARD | 393,700 | 0 | 393,700 | 2,645,664 | Neu | +100,0% | |
| Swiss National Bank | 272,100 | 0 | 272,100 | 1,828,512 | Neu | +100,0% | |
| Invesco Ltd. | 259,380 | 0 | 259,380 | 1,743,033 | Neu | +100,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 248,989 | 0 | 248,989 | 1,673,206 | Neu | +100,0% | |
| WOLVERINE ASSET MANAGEMENT LLC | 223,800 | 0 | 223,800 | 1,503,936 | Neu | +100,0% | |
| Walleye Capital LLC | 211,859 | 0 | 211,859 | 1,423,692 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 199,106 | 0 | 199,106 | 1,337,992 | Neu | +100,0% | |
| FARALLON CAPITAL MANAGEMENT LLC | 195,000 | 0 | 195,000 | 1,310,400 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 189,755 | 0 | 189,755 | 1,275,139 | Neu | +100,0% | |
| Eversept Partners, LP | 181,220 | 0 | 181,220 | 1,217,798 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 166,549 | 0 | 166,549 | 1,119,206 | Neu | +100,0% | |
| ALLIANCEBERNSTEIN L.P. | 163,213 | 0 | 163,213 | 1,096,791 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 159,013 | 0 | 159,013 | 1,068,567 | Neu | +100,0% | |
| Legal & General Group Plc | 152,225 | 0 | 152,225 | 1,022,951 | Neu | +100,0% | |
| AQR CAPITAL MANAGEMENT LLC | 146,733 | 0 | 146,733 | 986,045 | Neu | +100,0% | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 133,404 | 0 | 133,404 | 896,475 | Neu | +100,0% | |
| OPPENHEIMER & CO INC | 105,168 | 35,811 | 69,357 | 856,068 | Aufgestockt | +193,7% | |
| PROFUND ADVISORS LLC | 121,693 | 0 | 121,693 | 817,777 | Neu | +100,0% | |
| DEUTSCHE BANK AG\ | 119,924 | 0 | 119,924 | 805,889 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Stand: 31.03.2026
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| OPPENHEIMER & CO INC | 105,168 | 856,068 | 100.00 |